Speaker illustration

Miss Stine Andersen

Aarhus University Hospital, Aarhus (Denmark)

Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in pulmonary arterial hypertension and right heart failure

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Pulmonary hypertension: progress in management, impact on outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb